SEC Form 4 · accession 0000884731-16-000029
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas DesRosier
Officer — EVP, General Counsel
Period of report
Feb 18, 2016
Accepted (ET)
Mar 30, 2016 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 18, 2016 | M | 55,000 | $0.00 | A | 55,000 | D | |
| Common Stock | Feb 18, 2016 | F | 18,370 | $5.03 | D | 36,630 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | — | Feb 18, 2016 | M | 55,000 | D | — | — | Common Stock | 55,000 | 55,000 | D |
Explanation of responses
- F1Shares were acquired upon the vesting of a Restricted Stock Unit dated 02/18/2015
- F2Represents shares withheld to satisfy withholding tax requirements
- F3Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- F4Restricted stock units vest 50% per year on each February 18 of 2016 and 2017.